Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other financing activities (2016)

Iradimed has reported Other financing activities over the past 3 years, most recently at $53122.0 for Q4 2016.

  • Quarterly Other financing activities fell 93.75% to $53122.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $603553.0 through Dec 2016, down 65.08% year-over-year, with the annual reading at -$1.1 million for FY2025, 763.36% down from the prior year.
  • Other financing activities was $53122.0 for Q4 2016 at Iradimed, down from $284337.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.8 million in Q3 2014 and troughed at $49807.0 in Q2 2015.
  • The 3-year median for Other financing activities is $209515.0 (2016), against an average of $463696.8.
  • The largest YoY upside for Other financing activities was 320.65% in 2016 against a maximum downside of 93.75% in 2016.
  • A 3-year view of Other financing activities shows it stood at $1.8 million in 2014, then tumbled by 53.81% to $850449.0 in 2015, then plummeted by 93.75% to $53122.0 in 2016.
  • Per Business Quant, the three most recent readings for IRMD's Other financing activities are $53122.0 (Q4 2016), $284337.0 (Q3 2016), and $209515.0 (Q2 2016).